Enhanced Nrf2 activation (via Keap1-KD) attenuated methionine- and choline-deficient diet-induced fatty liver by increasing hepatic antioxidant and detoxification capacity [18]. The gene discussed is NFE2L2; the disease is Hepatic steatosis.